VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 11 of Oncotarget features Figure 4, "Schematic of TAM pathway signaling in innate immune cells," from Wang, et al.
|
|
Table of Contents
Research Papers: Gerotarget (Focus on Aging)
|
| Effect of the diet type and temperature on the C elegans transcriptome |
|
https://doi.org/10.18632/oncotarget.23563
|
| 9556-9571 |
|
| Agerelated changes in expression and signaling of TAM receptor inflammatory regulators in monocytes |
|
https://doi.org/10.18632/oncotarget.23851
|
| 9572-9580 |
|
| CGEF1 regulates mTORC1 signaling during adult longevity and stress response in C elegans |
|
https://doi.org/10.18632/oncotarget.24039
|
| 9581-9595 |
Research Papers: Immunology
|
| Overexpression of CuZn SOD in Brucella abortus suppresses bacterial intracellular replication via downregulation of Sar1 activity |
|
https://doi.org/10.18632/oncotarget.24073
|
| 9596-9607 |
Research Papers
|
| SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents |
|
https://doi.org/10.18632/oncotarget.20033
|
| 9608-9617 |
|
| Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage |
|
https://doi.org/10.18632/oncotarget.22709
|
| 9618-9631 |
|
| NFATmediated defects in erythropoiesis cause anemia in Il2−/− mice |
|
https://doi.org/10.18632/oncotarget.23745
|
| 9632-9644 |
|
| Molecular characterization of breast cancer cell response to metabolic drugs |
|
https://doi.org/10.18632/oncotarget.24047
|
| 9645-9660 |
|
| Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by PhosphoErbB3 expression |
|
https://doi.org/10.18632/oncotarget.23800
|
| 9661-9671 |
|
| TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer |
|
https://doi.org/10.18632/oncotarget.23822
|
| 9672-9684 |
|
| Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation |
|
https://doi.org/10.18632/oncotarget.23859
|
| 9685-9705 |
|
| Pololike kinase inhibitor volasertib marginally enhances the efficacy of the novel Fcengineered antiCD33 antibody BI 836858 in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.23880
|
| 9706-9713 |
|
| Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms |
|
https://doi.org/10.18632/oncotarget.23882
|
| 9714-9727 |
|
| Cell banking for regulatory T cellbased therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype |
|
https://doi.org/10.18632/oncotarget.23887
|
| 9728-9740 |
|
| Efficacy of histologyagnostic and molecularlydriven HER2 inhibitors for refractory cancers |
|
https://doi.org/10.18632/oncotarget.24188
|
| 9741-9750 |
|
| CXCR2 is a negative regulator of p21 in p53dependent and independent manner via Aktmediated Mdm2 in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24231
|
| 9751-9765 |
|
| Evaluation of tenascinC by tenatumomab in Tcell nonHodgkin lymphomas identifies a new target for radioimmunotherapy |
|
https://doi.org/10.18632/oncotarget.23919
|
| 9766-9775 |
|
| Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal Bcell lymphoma and survival in a lymphoma xenograft murine model |
|
https://doi.org/10.18632/oncotarget.24267
|
| 9776-9788 |
|
| Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.23929
|
| 9789-9807 |
|
| The cRaf modulator RRD251 enhances nuclear cRaf/GSK3/VDR axis signaling and augments 125dihydroxyvitamin D3induced differentiation of HL60 myeloblastic leukemia cells |
|
https://doi.org/10.18632/oncotarget.24275
|
| 9808-9824 |
|
| Interleukin 17 and peripheral IL17expressing T cells are negatively correlated with the overall survival of head and neck cancer patients |
|
https://doi.org/10.18632/oncotarget.23934
|
| 9825-9837 |
|
| Unbiased compoundprotein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells |
|
https://doi.org/10.18632/oncotarget.24305
|
| 9838-9851 |
|
| Prominent role of RAB39ARXRB axis in cancer development and stemness |
|
https://doi.org/10.18632/oncotarget.23955
|
| 9852-9866 |
|
| Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid |
|
https://doi.org/10.18632/oncotarget.23984
|
| 9867-9874 |
|
| RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases |
|
https://doi.org/10.18632/oncotarget.23986
|
| 9875-9884 |
|
| Targeting intracellular B2 receptors using novel cellpenetrating antagonists to arrest growth and induce apoptosis in human triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.24009
|
| 9885-9906 |
|
| Reversible LSD1 inhibition with HCI2509 induces the p53 gene expression signature and disrupts the MYCN signature in highrisk neuroblastoma cells |
|
https://doi.org/10.18632/oncotarget.24035
|
| 9907-9924 |
|
| Bile acid metabolism regulated by the gut microbiota promotes nonalcoholic steatohepatitisassociated hepatocellular carcinoma in mice |
|
https://doi.org/10.18632/oncotarget.24066
|
| 9925-9939 |
|
| CXCR4: A new player in vestibular schwannoma pathogenesis |
|
https://doi.org/10.18632/oncotarget.24119
|
| 9940-9950 |
|
| Urokinasederived peptide UP7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation |
|
https://doi.org/10.18632/oncotarget.24131
|
| 9951-9962 |
|
| HMGA2 enhances 5fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway |
|
https://doi.org/10.18632/oncotarget.24133
|
| 9963-9974 |
|
| Potent antitumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits |
|
https://doi.org/10.18632/oncotarget.24160
|
| 9975-9991 |
|
| Prognostic value of neutrophiltolymphocyte ratio and platelettolymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.24173
|
| 9992-10004 |
|
| Evaluation of tumor hypoxia prior to radiotherapy in intermediaterisk prostate cancer using 18Ffluoromisonidazole PET/CT: a pilot study |
|
https://doi.org/10.18632/oncotarget.24234
|
| 10005-10015 |
|
| Effect of traumatic brain injury on nicotineinduced modulation of dopamine release in the striatum and nucleus accumbens shell |
|
https://doi.org/10.18632/oncotarget.24245
|
| 10016-10028 |
|
| CD44 exerts a functional role during EMT induction in cisplatinresistant head and neck cancer cells |
|
https://doi.org/10.18632/oncotarget.24252
|
| 10029-10041 |
|
| Mutational landscape of radiationassociated angiosarcoma of the breast |
|
https://doi.org/10.18632/oncotarget.24273
|
| 10042-10053 |
|
| Impact of glutathione peroxidase 4 on cell proliferation angiogenesis and cytokine production in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24300
|
| 10054-10068 |
|
| Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain |
|
https://doi.org/10.18632/oncotarget.24311
|
| 10069-10082 |
|
| Clinicopathological significance of CHFR promoter methylation in gastric cancer: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.23394
|
| 10083-10090 |
Clinical Research Papers
|
| Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications |
|
https://doi.org/10.18632/oncotarget.23497
|
| 10091-10099 |
|
| Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer |
|
https://doi.org/10.18632/oncotarget.24071
|
| 10100-10109 |
|
| A phase1/2 study of adenovirusp53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer |
|
https://doi.org/10.18632/oncotarget.24118
|
| 10110-10117 |
|
| Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.24076
|
| 10118-10127 |
|
| 18Ffluorothymidine PET for predicting survival in patients with resectable pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.24176
|
| 10128-10134 |
Reviews
|
| Metformin and berberine two versatile drugs in treatment of common metabolic diseases |
|
https://doi.org/10.18632/oncotarget.20807
|
| 10135-10146 |
|
| Newly developed antiangiogenic therapy in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.23755
|
| 10147-10163 |
|
| The novel strategies for nextgeneration cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer |
|
https://doi.org/10.18632/oncotarget.24309
|
| 10164-10174 |
Case Reports
|
| Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and intermetastatic molecular heterogeneity at progression |
|
https://doi.org/10.18632/oncotarget.23699
|
| 10175-10183 |
Corrections
|
| Correction: Multiparametric imaging using 18FFDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy |
|
https://doi.org/10.18632/oncotarget.24463
|
| 10184-10184 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
